Form 4: InspireMD Director Thomas J. Kester Acquires and Disposes of Shares in Recent Transaction

Director Thomas J. Kester reports acquiring and disposing of InspireMD shares and warrants on May 28, 2024.

Summary

• On May 28, 2024, Thomas J. Kester, a director of InspireMD, Inc. [NSPR], engaged in a transaction involving the company's securities.
• Kester acquired 30,625 shares of common stock at a price of $1.3827 per share.
• Concurrently, Kester disposed of 326,652 shares of common stock.
• Kester also acquired 30,625 Series H Warrants with an exercise price of $1.3827, exercisable from May 15, 2023, and expiring on June 26, 2024.
• Following the reported transactions, Kester's beneficial ownership includes derivative securities.

Sentiment

Score: 5

Explanation: The document is a standard SEC filing detailing insider transactions. It doesn't inherently convey positive or negative sentiment, but rather provides factual information about stock and warrant activity.

Industry Context

This filing is a routine disclosure of insider transactions, which are common in publicly traded companies. It provides transparency into the trading activities of company insiders.

Stakeholder Impact

• The transaction may be of interest to shareholders as it provides insight into the actions of a company director.

Key Dates